Inhibiting the inhibitor: a new route to bone anabolism
- PMID: 19335216
- DOI: 10.1359/jbmr.090228
Inhibiting the inhibitor: a new route to bone anabolism
Comment on
-
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.J Bone Miner Res. 2009 Apr;24(4):578-88. doi: 10.1359/jbmr.081206. J Bone Miner Res. 2009. PMID: 19049336
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources